Follow
Satish Pillai
Satish Pillai
Senior Investigator, Vitalant Research Institute; Professor, UCSF
Verified email at ucsf.edu - Homepage
Title
Cited by
Cited by
Year
First case of 2019 novel coronavirus in the United States
ML Holshue, C DeBolt, S Lindquist, KH Lofy, J Wiesman, H Bruce, ...
New England journal of medicine 382 (10), 929-936, 2020
76122020
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
21452019
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Q Yu, R König, S Pillai, K Chiles, M Kearney, S Palmer, D Richman, ...
Nature structural & molecular biology 11 (5), 435-442, 2004
7392004
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 131-138, 2019
5122019
Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019–February 4, 2020
A Patel
MMWR. Morbidity and mortality weekly report 69, 2020
5052020
HIV rebounds from latently infected cells, rather than from continuing low-level replication
B Joos, M Fischer, H Kuster, SK Pillai, JK Wong, J Böni, B Hirschel, ...
Proceedings of the National Academy of Sciences 105 (43), 16725-16730, 2008
3502008
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient
SA Yukl, E Boritz, M Busch, C Bentsen, TW Chun, D Douek, E Eisele, ...
PLoS pathogens 9 (5), e1003347, 2013
3352013
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States
Nature medicine 26 (6), 861-868, 2020
3322020
Numbering positions in HIV relative to HXB2CG
B Korber, BT Foley, C Kuiken, SK Pillai, JG Sodroski
Human retroviruses and AIDS 3, 102-111, 1998
2371998
Washington state 2019-nCoV case investigation team
ML Holshue, C DeBolt, S Lindquist, KH Lofy, J Wiesman, H Bruce, ...
First case of, 929-936, 2019
2332019
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
DL Ng, GM Goldgof, BR Shy, AG Levine, J Balcerek, SP Bapat, J Prostko, ...
Nature communications 11 (1), 4698, 2020
1912020
A new perspective on V3 phenotype prediction
S Pillai, B Good, D Richman, J Corbeil
AIDS research and human retroviruses 19 (2), 145-149, 2003
1832003
Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates
AJ Low, W Dong, D Chan, T Sing, R Swanstrom, M Jensen, S Pillai, ...
Aids 21 (14), F17-F24, 2007
1792007
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy
MC Strain, S Letendre, SK Pillai, T Russell, CC Ignacio, HF Gunthard, ...
Journal of virology 79 (3), 1772-1788, 2005
1692005
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection …
SR Bialek, D Allen, F Alvarado-Ramy, R Arthur, A Balajee, D Bell, S Best, ...
American Journal of Transplantation 14 (7), 1693-1699, 2014
1652014
In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells
JK Wong, MC Strain, R Porrata, E Reay, S Sankaran-Walters, CC Ignacio, ...
PLoS pathogens 6 (1), e1000748, 2010
1652010
Update: interim guidance for preconception counseling and prevention of sexual transmission of Zika virus for persons with possible Zika virus exposure—United States …
EE Petersen, D Meaney-Delman, R Neblett-Fanfair, F Havers, T Oduyebo, ...
Morbidity and Mortality Weekly Report 65 (39), 1077-1081, 2016
1512016
Antibiotics in laboratory medicine
SK Pillai, RC Moellering, GM Eliopoulos, V Lorian
Antibiotics in Laboratory Medicine. 5th ed. Baltimore, MD: Lippincott …, 2005
1512005
Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells
E Battivelli, MS Dahabieh, M Abdel-Mohsen, JP Svensson, ...
Elife 7, e34655, 2018
1452018
Short-course toll-like receptor 9 agonist treatment impacts innate immunity and plasma viremia in individuals with human immunodeficiency virus infection
L Vibholm, MH Schleimann, JF Hĝjen, T Benfield, R Offersen, ...
Clinical Infectious Diseases 64 (12), 1686-1695, 2017
1432017
The system can't perform the operation now. Try again later.
Articles 1–20